ADMA BIOLOGICS, INC.

financial.report · SEC EDGAR

This page reproduces a recorded source event. It is not a live quote, forecast, recommendation or legal conclusion.

Event type

financial.report

Occurred

2026-03-31

Reported

2026-05-06

Disclosure lag

36 days

Context

links are based on the recorded entity type

Field	Recorded value
Entity	ADMA BIOLOGICS, INC.
Source	SEC EDGAR ↗
Source identifier	companyfacts/CIK0001368514/2026-07-26
Event ID	#29232

Recorded payload

JSON payload as stored after parsing

{
  "accession": "0001140361-26-019336",
  "canonical_covered": 12,
  "canonical_total": 12,
  "fiscal_period": "Q1",
  "fiscal_year": 2026,
  "form": "10-Q",
  "mapped_tag_share": 0.03811659192825112,
  "metrics": {
    "cash_and_equivalents": 138153000,
    "earnings_per_share_basic": 0.19,
    "earnings_per_share_diluted": 0.19,
    "gross_profit": 80750000,
    "net_income": 45328000,
    "operating_cash_flow": 58249000,
    "operating_income": 58274000,
    "revenue": 114493000,
    "shareholders_equity": 390325000,
    "shares_outstanding": 232288977,
    "total_assets": 665184000,
    "total_liabilities": 274859000
  },
  "metrics_reported": 12,
  "period_end": "2026-03-31"
}

Source: SEC EDGAR · as of 2026-05-06T00:00:00Z